Abeona Therapeutics (ABEO) Competitors $6.56 +1.26 (+23.77%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO vs. WVE, OPK, ETNB, COLL, GERN, MLYS, HROW, SYRE, ZYME, and RCUSShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Wave Life Sciences (WVE), OPKO Health (OPK), 89bio (ETNB), Collegium Pharmaceutical (COLL), Geron (GERN), Mineralys Therapeutics (MLYS), Harrow (HROW), Spyre Therapeutics (SYRE), Zymeworks (ZYME), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical preparations" industry. Abeona Therapeutics vs. Wave Life Sciences OPKO Health 89bio Collegium Pharmaceutical Geron Mineralys Therapeutics Harrow Spyre Therapeutics Zymeworks Arcus Biosciences Abeona Therapeutics (NASDAQ:ABEO) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation. Does the media refer more to ABEO or WVE? In the previous week, Wave Life Sciences had 2 more articles in the media than Abeona Therapeutics. MarketBeat recorded 11 mentions for Wave Life Sciences and 9 mentions for Abeona Therapeutics. Wave Life Sciences' average media sentiment score of 1.00 beat Abeona Therapeutics' score of 0.45 indicating that Wave Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abeona Therapeutics 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Wave Life Sciences 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of ABEO or WVE? 80.6% of Abeona Therapeutics shares are owned by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are owned by institutional investors. 5.4% of Abeona Therapeutics shares are owned by company insiders. Comparatively, 29.1% of Wave Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend ABEO or WVE? Abeona Therapeutics currently has a consensus price target of $18.75, indicating a potential upside of 185.82%. Wave Life Sciences has a consensus price target of $21.17, indicating a potential upside of 174.18%. Given Abeona Therapeutics' higher possible upside, equities research analysts clearly believe Abeona Therapeutics is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is ABEO or WVE more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Abeona Therapeutics' return on equity of -203.27% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Abeona TherapeuticsN/A -203.27% -64.56% Wave Life Sciences -66.50%-280.57%-52.90% Does the MarketBeat Community prefer ABEO or WVE? Abeona Therapeutics received 158 more outperform votes than Wave Life Sciences when rated by MarketBeat users. Likewise, 69.39% of users gave Abeona Therapeutics an outperform vote while only 67.90% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformAbeona TherapeuticsOutperform Votes52669.39% Underperform Votes23230.61% Wave Life SciencesOutperform Votes36867.90% Underperform Votes17432.10% Which has more risk & volatility, ABEO or WVE? Abeona Therapeutics has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -0.93, suggesting that its stock price is 193% less volatile than the S&P 500. Which has stronger valuation & earnings, ABEO or WVE? Abeona Therapeutics has higher earnings, but lower revenue than Wave Life Sciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbeona Therapeutics$3.50M91.47-$54.19M-$2.19-3.00Wave Life Sciences$108.30M10.94-$57.51M-$0.79-9.77 SummaryAbeona Therapeutics and Wave Life Sciences tied by winning 9 of the 18 factors compared between the two stocks. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$320.13M$6.89B$5.56B$7.83BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-2.447.4422.4818.48Price / Sales91.47242.70394.56103.59Price / CashN/A65.8538.1834.62Price / Book10.936.516.774.25Net Income-$54.19M$143.21M$3.22B$248.23M7 Day Performance21.71%1.98%1.48%0.89%1 Month Performance47.42%6.89%3.99%3.53%1 Year Performance67.77%-2.52%16.15%5.08% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.8204 of 5 stars$6.56+23.8%$18.75+185.8%+58.5%$320.13M$3.50M-2.44N/AAnalyst ForecastShort Interest ↑News CoverageHigh Trading VolumeWVEWave Life Sciences4.313 of 5 stars$6.12+3.4%$22.18+262.4%+56.6%$939.33M$108.30M-5.51240Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsOPKOPKO Health4.4856 of 5 stars$1.37-3.5%$2.75+100.7%+13.1%$920.02M$713.14M-7.214,200Earnings ReportNews CoverageETNB89bio2.7852 of 5 stars$6.27+3.5%$27.56+339.5%-5.8%$915.32MN/A-2.1540Upcoming EarningsPositive NewsCOLLCollegium Pharmaceutical4.051 of 5 stars$26.91-0.4%$43.60+62.0%-26.9%$864.67M$631.45M11.60210Upcoming EarningsGERNGeron4.0013 of 5 stars$1.35+6.3%$5.75+325.9%-64.1%$859.83M$76.99M-4.2270Upcoming EarningsMLYSMineralys Therapeutics2.3896 of 5 stars$13.24-0.8%$33.00+149.2%+16.0%$858.96MN/A-3.6428Upcoming EarningsShort Interest ↑HROWHarrow2.3419 of 5 stars$23.24-3.1%$60.50+160.3%+143.1%$828.60M$199.61M-24.72182Positive NewsGap DownSYRESpyre Therapeutics1.7682 of 5 stars$13.57+7.1%$49.57+265.3%-53.9%$817.95M$890,000.00-1.82100Upcoming EarningsNews CoveragePositive NewsZYMEZymeworks2.7711 of 5 stars$11.75+1.9%$21.00+78.7%+51.6%$817.53M$76.30M-7.83460Upcoming EarningsPositive NewsRCUSArcus Biosciences2.0512 of 5 stars$7.68-2.5%$30.25+293.9%-42.6%$807.46M$258M-2.44500Upcoming EarningsPositive NewsGap Down Related Companies and Tools Related Companies Wave Life Sciences Alternatives OPKO Health Alternatives 89bio Alternatives Collegium Pharmaceutical Alternatives Geron Alternatives Mineralys Therapeutics Alternatives Harrow Alternatives Spyre Therapeutics Alternatives Zymeworks Alternatives Arcus Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABEO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABEO Stock Free ABEO Stock Alerts